tykundegex Monday, 02/17/20 03:15:18 AM Re: None Post # of 174 The company recently announced another clinic that will offer PoNS treatment, bringing the total to 8 in Canada, slightly ahead of the number they anticipated to have by the end of 2019. However, the latest clinic is a one-physician outfit, 40 miles from the largest city on Vancouver island, with a population of under 100,000 people, so it's hardly a "material event" worthy of an 8K. If the patient outcomes from the initial larger clinics are as good as the company has been touting, the PT community will surely pick up on it and more clinics will sign-on. If they fail to get the word out and build momentum by the end of summer 2020, then I'm inclined to think it's not going happen. And if there is no commercial traction in Canada, then a US FDA approval would be a non-event. If, on the other hand, we do get strong testimonials from patients and physicians, and the company can get their devices into more Canadian clinics, it would bode well for the stock (finally) and FDA approval would be an inflection point. For now, I'm watching this space with a speculative position (well into the red), and ready to invest more should we see encouraging progress.